Drug Trial Radar · NCT00017784
Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection
Last checked: Nov 20, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
500
Actual
Start
Not stated
Primary completion
Not stated
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Aug 31, 2001
Design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to make valganciclovir available, before it is approved for marketing, to HIV-infected patients who have cytomegalovirus (CMV) retinitis (eye infection) and cannot take drugs by injection. This study also will look at the safety of using valganciclovir as starting and/or ongoing therapy. CMV can cause serious AIDS-related infections in patients with HIV. Drugs that are effective against CMV eye infections can be given only by injection; this calls for a thin tube to be placed into a vein in the chest so that the patient is not put through getting too many needle sticks. An experimental drug, valganciclovir, is similar to 1 of these approved drugs, ganciclovir, but is more convenient and easier to use since it can be taken by mouth. Once in the body, valganciclovir changes to ganciclovir. Studies have shown that valganciclovir tablets can result in the same level of ganciclovir in the blood as ganciclovir injection.
Conditions
- Cytomegalovirus Retinitis
- HIV Infections
Interventions
ValganciclovirDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
9 sites in 2 countries. Site status is shown where the registry gives one.
Retina - Vitreous Associates Med Group
Beverly Hills, California
Wilbert Jordan
Paramount, California
Quest Clinical Research
San Francisco, California
Santa Clara Valley Med Ctr
San Jose, California
IDC Research Initiative
Altamonte Springs, Florida
Ingenix Kern McNeill Decatur
Atlanta, Georgia
Nashville Health Management Foundation / Vanderbilt Univ
Nashville, Tennessee
North Texas Infectious Disease Consultants
Dallas, Texas
Fundacion Gastroenterologia de Diego
San Juan, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.